Inverse Association Between Histologic Inflammation in Needle Biopsy Specimens and Prostate Cancer in Men With Serum PSA of 10-50 ng/mL

Urology

Volumn 72, Issue 6, 2008, Pages 1194-1197

  Terakawa, Tomoaki ^a   Miyake, Hideaki ^a   Kanomata, Naoki ^b   Kumano, Masafumi ^b   Takenaka, Atsushi ^b   Fujisawao, Masato ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY;

AGED; BIOPSY, NEEDLE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 56449087214     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.07.028     Document Type: Article

References (19)

1. Stephan C., Jung K., Lein M., et al. PSA and other tissue kallikreins for prostate cancer detection. Eur J Cancer 43 (2007) 1918-1926
2. Oesterling J.E. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145 (1991) 907-923
3. Stamey T.A., Yang N., Hay A.R., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317 (1987) 909-916
4. Okada K., Kojima M., Naya Y., et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer. Urology 55 (2000) 892-898
5. Chang S.G., Kim C.S., Jeon S.H., et al. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?. Int J Urol 13 (2006) 122-126
6. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156-1161
7. Catalona W.J., Southwick P.C., Slawin K.M., et al. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology 56 (2000) 255-260
8. Brawer M.K., Cheli C.D., Neaman I.E., et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol 163 (2000) 1476-1480
9. Garzotto M., Park Y., Mongoue-Tchokote S., et al. Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies. Cancer 104 (2005) 1911-1917
10. Miyake H., Sakai I., Ishimura T., et al. Significance of cancer detection in the anterior lateral horn on systematic prostate biopsy: impact on pathological findings of radical prostatectomy specimens. BJU Int 93 (2004) 53-59
11. Miyake H., Harada K., Inoue T.A., et al. Additional sampling of dorsal apex on systematic prostate biopsy: Impact on early detection of prostate cancer. Urology 69 (2007) 738-742
12. De Marzo A.M., Marchi V.L., Epstein J.I., et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155 (1999) 1985-1992
13. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 148 (1983) 839-843
14. Hernández J., and Thompson I.M. Prostate-specific antigen: A review of the validation of the most commonly used cancer biomarker. Cancer 101 (2004) 894-904
15. Gosselaar C., Roobol M.J., and Schröder F.H. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: Aggressive or insignificant?. BJU Int 95 (2005) 231-237
16. Kato T., Suzuki H., Komiya A., et al. Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer. Int J Urol 13 (2006) 915-919
17. Papsidero L.D., Kuriyama M., Wang M.C., et al. Prostate antigen: A marker for human prostate epithelial cells. J Natl Cancer Inst 66 (1981) 37-42
18. Hasui Y., Marutsuka K., Asada Y., et al. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 25 (1994) 91-96
19. Karazanashvili G., and Managadze L. Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol 39 (2001) 538-543